Revolution Medicines, Inc. (RVMD)
117.53
+1.31
(+1.13%)
USD |
NASDAQ |
Jan 21, 16:00
115.05
-2.48
(-2.11%)
After-Hours: 20:00
Revolution Medicines EPS Diluted (Quarterly): -1.613 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| AbbVie, Inc. | 0.0993 |
| Eli Lilly & Co. | 6.211 |
| Disc Medicine, Inc. | -1.772 |
| Solid Biosciences, Inc. | -0.4848 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -305.21M |
| Total Expenses (Quarterly) | 305.21M |
| Enterprise Value | 20.95B |
| Earnings Yield | -4.41% |
| Normalized Earnings Yield | -4.399 |